Brought to you by
ECR 2019 / C-1620
Usefulness of fusion MRI in ADC analysis after neoadjuvant chemotherapy in patients with breast cancer
Congress: ECR 2019
Poster No.: C-1620
Type: Scientific Exhibit
Keywords: Breast, MR-Diffusion/Perfusion, MR, MR-Functional imaging, Contrast agent-intravenous, Chemotherapy, Cancer, Neoplasia
Authors: N. Belleggia1, C. De Cataldo1, E. Di Cesare1, C. Masciocchi1, A. Di Sibio2; 1L'Aquila/IT, 2L'Aquila, ITALY/IT
DOI:10.26044/ecr2019/C-1620

References

  1. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW (2002) In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging.15(6):693-704.
  2. Dorrius MD, Dijkstra H, Oudkerk M, Sijens PE (2014) Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis. Eur Radiol. 24(11):2835-47.
  3. Xue-Ying Hu1,*, Ying Li1,*, Guan-Qiao Jin1, Shao-Lv Lai1, Xiang-Yang Huang1 and Dan-Ke Su (2017).  Diffusion-weighted MR imaging in prediction of response to neoadjuvant chemotherapy in patients    with breast cancer.
POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more